244 related articles for article (PubMed ID: 23917306)
1. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial-mesenchymal transition in vitro.
Wang L; Zhang J; Yang X; Chang YW; Qi M; Zhou Z; Zhang J; Han B
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):301-7. PubMed ID: 23917306
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
3. ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.
Wang L; Li Y; Yang X; Yuan H; Li X; Qi M; Chang YW; Wang C; Fu W; Yang M; Zhang J; Han B
Prostate; 2014 May; 74(6):647-58. PubMed ID: 24435928
[TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
5. SOX4 is activated by C-MYC in prostate cancer.
Dong H; Hu J; Wang L; Qi M; Lu N; Tan X; Yang M; Bai X; Zhan X; Han B
Med Oncol; 2019 Sep; 36(11):92. PubMed ID: 31560094
[TBL] [Abstract][Full Text] [Related]
6. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
7. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
8. The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression.
Liu H; Wu Z; Zhou H; Cai W; Li X; Hu J; Gao L; Feng T; Wang L; Peng X; Qi M; Liu L; Han B
Neoplasia; 2019 Aug; 21(8):765-776. PubMed ID: 31238254
[TBL] [Abstract][Full Text] [Related]
9. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
10. LINC00992 exerts oncogenic activities in prostate cancer via regulation of SOX4.
Fu C; Xin J; Zhang W; Lai J; Huang Z
Exp Cell Res; 2021 Nov; 408(1):112855. PubMed ID: 34599930
[TBL] [Abstract][Full Text] [Related]
11. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer.
Liu Y; Zeng S; Jiang X; Lai D; Su Z
Tumour Biol; 2017 May; 39(5):1010428317694539. PubMed ID: 28466783
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition.
Ruan H; Yang H; Wei H; Xiao W; Lou N; Qiu B; Xu G; Song Z; Xiao H; Liu L; Zhou Y; Hu W; Chen K; Chen X; Zhang X
Int J Oncol; 2017 Jul; 51(1):336-346. PubMed ID: 28534986
[TBL] [Abstract][Full Text] [Related]
14. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-19a-3p suppresses invasion and metastasis of prostate cancer via inhibiting SOX4.
Feng YG; Zhao JF; Xiao L; Rao WY; Ran C; Xiao YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6245-6251. PubMed ID: 30338791
[TBL] [Abstract][Full Text] [Related]
16. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
Liu Y; Qin Z; Yang K; Liu R; Xu Y
Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
19. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
20. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
